Neubond, a spinout from Imperial College London, has secured £1.5 million in seed funding from Waseda University Ventures, SFC Capital, and New Wave Ventures, to bring its at-home stroke rehabilitation wristband to market.
Waseda University Ventures, a deeptech venture capital fund based in Tokyo and backed by one of Japan’s leading private research universities, says this is its first investment in a UK company.
In a pilot study with 15 patients, users improved their range of motion by 30% after one month. The new funding will help the device get MHRA certification and support a key clinical study at Charing Cross Hospital.
After a stroke, patients often try to move but do not get any sensory feedback because the link between intention and action is broken. Neubond, a London spinout from Imperial College’s Department of Bioengineering, created a wristband to help restore this connection.
With £1.5 million in seed funding, the company aims to bring the device to patients at home. Waseda University Ventures, a deeptech fund from Tokyo, set up in 2022 by Waseda University, led the funding round.
